Rapid prediction of 1-year efficacy of tofacitinib for treating refractory ulcerative colitis

Detalles Bibliográficos
Autores principales: Shimizu, Hiromichi, Fujii, Toshimitsu, Hibiya, Shuji, Motobayashi, Maiko, Suzuki, Kohei, Takenaka, Kento, Saito, Eiko, Nagahori, Masakazu, Ohtsuka, Kazuo, Watanabe, Mamoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2021
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873398/
https://www.ncbi.nlm.nih.gov/pubmed/32516866
http://dx.doi.org/10.5217/ir.2020.00030
_version_ 1783649376055328768
author Shimizu, Hiromichi
Fujii, Toshimitsu
Hibiya, Shuji
Motobayashi, Maiko
Suzuki, Kohei
Takenaka, Kento
Saito, Eiko
Nagahori, Masakazu
Ohtsuka, Kazuo
Watanabe, Mamoru
author_facet Shimizu, Hiromichi
Fujii, Toshimitsu
Hibiya, Shuji
Motobayashi, Maiko
Suzuki, Kohei
Takenaka, Kento
Saito, Eiko
Nagahori, Masakazu
Ohtsuka, Kazuo
Watanabe, Mamoru
author_sort Shimizu, Hiromichi
collection PubMed
description
format Online
Article
Text
id pubmed-7873398
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Korean Association for the Study of Intestinal Diseases
record_format MEDLINE/PubMed
spelling pubmed-78733982021-02-18 Rapid prediction of 1-year efficacy of tofacitinib for treating refractory ulcerative colitis Shimizu, Hiromichi Fujii, Toshimitsu Hibiya, Shuji Motobayashi, Maiko Suzuki, Kohei Takenaka, Kento Saito, Eiko Nagahori, Masakazu Ohtsuka, Kazuo Watanabe, Mamoru Intest Res Brief Communication Korean Association for the Study of Intestinal Diseases 2021-01 2020-06-11 /pmc/articles/PMC7873398/ /pubmed/32516866 http://dx.doi.org/10.5217/ir.2020.00030 Text en © Copyright 2021. Korean Association for the Study of Intestinal Diseases. All rights reserved. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Communication
Shimizu, Hiromichi
Fujii, Toshimitsu
Hibiya, Shuji
Motobayashi, Maiko
Suzuki, Kohei
Takenaka, Kento
Saito, Eiko
Nagahori, Masakazu
Ohtsuka, Kazuo
Watanabe, Mamoru
Rapid prediction of 1-year efficacy of tofacitinib for treating refractory ulcerative colitis
title Rapid prediction of 1-year efficacy of tofacitinib for treating refractory ulcerative colitis
title_full Rapid prediction of 1-year efficacy of tofacitinib for treating refractory ulcerative colitis
title_fullStr Rapid prediction of 1-year efficacy of tofacitinib for treating refractory ulcerative colitis
title_full_unstemmed Rapid prediction of 1-year efficacy of tofacitinib for treating refractory ulcerative colitis
title_short Rapid prediction of 1-year efficacy of tofacitinib for treating refractory ulcerative colitis
title_sort rapid prediction of 1-year efficacy of tofacitinib for treating refractory ulcerative colitis
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873398/
https://www.ncbi.nlm.nih.gov/pubmed/32516866
http://dx.doi.org/10.5217/ir.2020.00030
work_keys_str_mv AT shimizuhiromichi rapidpredictionof1yearefficacyoftofacitinibfortreatingrefractoryulcerativecolitis
AT fujiitoshimitsu rapidpredictionof1yearefficacyoftofacitinibfortreatingrefractoryulcerativecolitis
AT hibiyashuji rapidpredictionof1yearefficacyoftofacitinibfortreatingrefractoryulcerativecolitis
AT motobayashimaiko rapidpredictionof1yearefficacyoftofacitinibfortreatingrefractoryulcerativecolitis
AT suzukikohei rapidpredictionof1yearefficacyoftofacitinibfortreatingrefractoryulcerativecolitis
AT takenakakento rapidpredictionof1yearefficacyoftofacitinibfortreatingrefractoryulcerativecolitis
AT saitoeiko rapidpredictionof1yearefficacyoftofacitinibfortreatingrefractoryulcerativecolitis
AT nagahorimasakazu rapidpredictionof1yearefficacyoftofacitinibfortreatingrefractoryulcerativecolitis
AT ohtsukakazuo rapidpredictionof1yearefficacyoftofacitinibfortreatingrefractoryulcerativecolitis
AT watanabemamoru rapidpredictionof1yearefficacyoftofacitinibfortreatingrefractoryulcerativecolitis

Ejemplares similares